Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study
W H Miller, L M Reyno, G R Loewen, et al.
British Journal of Cancer
|
March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
C A Townsley, P Major, L L Siu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
British Journal of Cancer
|
July 17, 2003
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
K Dalhoff, J Dancey, L Astrup, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
E A Eisenhauer, P Therasse, J Bogaerts, et al.
British Journal of Cancer
|
October 13, 2006
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
I Duran, J Kortmansky, D Singh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 8, 2012
Management of kidney cancer: canadian kidney cancer forum consensus update 2011
Mas Jewett, A Finelli, C Kollmannsberger, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study
W H Miller, L M Reyno, G R Loewen, et al.
British Journal of Cancer
|
March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
C A Townsley, P Major, L L Siu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
British Journal of Cancer
|
July 17, 2003
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
K Dalhoff, J Dancey, L Astrup, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
E A Eisenhauer, P Therasse, J Bogaerts, et al.
British Journal of Cancer
|
October 13, 2006
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
I Duran, J Kortmansky, D Singh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 8, 2012
Management of kidney cancer: canadian kidney cancer forum consensus update 2011
Mas Jewett, A Finelli, C Kollmannsberger, et al.
Page
of 4